Nicholas L. Fletcher, Weijing Chu, Pie Huda, Amber Prior, S. Gayathri, James Humphries, Christopher Howard, James L. Wood, Xiaoyan Zhang, Marina Silveira E. Silva, Benedict Lum, Malcolm Lim, Fiona Simpson, Kristofer J. Thurecht
Pb-nanomedicine, with no observed long term hematological effects. This work establishes a modular strategy for targeted TRT nanomedicine delivery. The platform has potential for broad applicability, including simultaneous delivery of diverse or synergistic payloads. These findings represent an important advance toward precision nanomedicine approaches in radionuclide therapy.